IRIX vs NTRA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRIX is a Hold and NTRA is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
IRIX’s FA Score shows that 1 FA rating(s) are green whileNTRA’s FA Score has 1 green FA rating(s).
- IRIX’s FA Score: 1 green, 4 red.
- NTRA’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
IRIX’s TA Score shows that 5 TA indicator(s) are bullish while NTRA’s TA Score has 5 bullish TA indicator(s).
- IRIX’s TA Score: 5 bullish, 5 bearish.
- NTRA’s TA Score: 5 bullish, 5 bearish.
Price Growth
IRIX (@Medical Specialties) experienced а +6.51% price change this week, while NTRA (@Medical Specialties) price change was +14.51% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +3.02%. For the same industry, the average monthly price growth was +0.79%, and the average quarterly price growth was -2.06%.
Reported Earning Dates
IRIX is expected to report earnings on Mar 06, 2025.
NTRA is expected to report earnings on Feb 26, 2025.
Industries' Descriptions
@Medical Specialties (+3.02% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
| IRIX | NTRA | IRIX / NTRA | |
| Capitalization | 48.4M | 11B | 0% |
| EBITDA | -6.79M | -397.8M | 2% |
| Gain YTD | -35.943 | 167.018 | -22% |
| P/E Ratio | N/A | N/A | - |
| Revenue | 56.4M | 1.08B | 5% |
| Total Cash | 9.82M | 879M | 1% |
| Total Debt | 1.26M | 442M | 0% |
IRIX | NTRA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 76 | 20 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 90 Overvalued | 62 Fair valued | |
PROFIT vs RISK RATING 1..100 | 98 | 25 | |
SMR RATING 1..100 | 98 | 95 | |
PRICE GROWTH RATING 1..100 | 61 | 35 | |
P/E GROWTH RATING 1..100 | 1 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NTRA's Valuation (62) in the Biotechnology industry is in the same range as IRIX (90) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to IRIX’s over the last 12 months.
NTRA's Profit vs Risk Rating (25) in the Biotechnology industry is significantly better than the same rating for IRIX (98) in the Medical Specialties industry. This means that NTRA’s stock grew significantly faster than IRIX’s over the last 12 months.
NTRA's SMR Rating (95) in the Biotechnology industry is in the same range as IRIX (98) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to IRIX’s over the last 12 months.
NTRA's Price Growth Rating (35) in the Biotechnology industry is in the same range as IRIX (61) in the Medical Specialties industry. This means that NTRA’s stock grew similarly to IRIX’s over the last 12 months.
IRIX's P/E Growth Rating (1) in the Medical Specialties industry is significantly better than the same rating for NTRA (100) in the Biotechnology industry. This means that IRIX’s stock grew significantly faster than NTRA’s over the last 12 months.
| IRIX | NTRA | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 81% | 1 day ago 70% |
| Stochastic ODDS (%) | 1 day ago 81% | 1 day ago 87% |
| Momentum ODDS (%) | 1 day ago 74% | 1 day ago 86% |
| MACD ODDS (%) | 1 day ago 78% | 1 day ago 82% |
| TrendWeek ODDS (%) | 1 day ago 77% | 1 day ago 84% |
| TrendMonth ODDS (%) | 1 day ago 76% | 1 day ago 85% |
| Advances ODDS (%) | 5 days ago 75% | 3 days ago 82% |
| Declines ODDS (%) | 3 days ago 81% | 9 days ago 80% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 78% |
| Aroon ODDS (%) | 1 day ago 80% | 1 day ago 87% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PEY | 22.77 | 0.39 | +1.74% |
| Invesco High Yield Eq Div Achiev™ ETF | |||
| DFRA | 32.43 | 0.29 | +0.91% |
| Donoghue Forlines Yld Enhd Rl Ast ETF | |||
| LEXI | 31.38 | 0.17 | +0.53% |
| Alexis Practical Tactical ETF | |||
| GMAR | 37.40 | 0.11 | +0.29% |
| FT Cboe Vest U.S. Eq Mod Buffr ETF - Mar | |||
| BSV | 77.32 | 0.01 | +0.01% |
| Vanguard Short-Term Bond ETF | |||
IRIX and
Correlation & Price change
A.I.dvisor indicates that over the last year, IRIX has been loosely correlated with NTRA. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if IRIX jumps, then NTRA could also see price increases.
| Ticker / NAME | Correlation To IRIX | 1D Price Change % | ||
|---|---|---|---|---|
| IRIX | 100% | +4.65% | ||
| NTRA - IRIX | 34% Loosely correlated | -1.24% | ||
| FNA - IRIX | 29% Poorly correlated | -3.74% | ||
| CNTGF - IRIX | 28% Poorly correlated | +10.00% | ||
| MDXH - IRIX | 26% Poorly correlated | +9.94% | ||
| SNN - IRIX | 26% Poorly correlated | +1.08% | ||
More | ||||
NTRA and
Correlation & Price change
A.I.dvisor indicates that over the last year, NTRA has been loosely correlated with VCYT. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if NTRA jumps, then VCYT could also see price increases.
| Ticker / NAME | Correlation To NTRA | 1D Price Change % | ||
|---|---|---|---|---|
| NTRA | 100% | -1.24% | ||
| VCYT - NTRA | 37% Loosely correlated | +1.67% | ||
| RDNT - NTRA | 36% Loosely correlated | +0.91% | ||
| CDNA - NTRA | 36% Loosely correlated | +2.44% | ||
| GH - NTRA | 36% Loosely correlated | +5.39% | ||
| IDXX - NTRA | 34% Loosely correlated | -0.31% | ||
More | ||||